HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

7,14-dihydroxypregn-4-ene-3,20-dione

progesterone metabolite; structure given in first source; RN given refers to (7alpha)-isomer; RN for cpd without isomeric designation not available 4/90
Also Known As:
7,14-dihydroxypregn-4-ene-3,20-dione, (7beta,14xi)-isomer; DPED
Networked: 12 relevant articles (0 outcomes, 3 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Agrón, Elvira: 3 articles (01/2022 - 03/2010)
2. Chew, Emily Y: 3 articles (01/2022 - 03/2010)
3. Cukras, Catherine: 2 articles (01/2019 - 03/2010)
4. Age-Related Eye Disease Study 2 Ancillary Spectral Domain Optical Coherence Tomography Study Group: 1 article (01/2022)
5. Cukras, Catherine A: 1 article (01/2022)
6. De Silva, Tharindu: 1 article (01/2022)
7. Keenan, Tiarnan D L: 1 article (01/2022)
8. Thavikulwat, Alisa T: 1 article (01/2022)
9. Toth, Cynthia A: 1 article (01/2022)
10. Fenech, Michael: 1 article (07/2021)

Related Diseases

1. Eye Diseases (Eye Disease)
2. Macular Degeneration (Age-Related Maculopathy)
3. Geographic Atrophy
4. Choroidal Neovascularization
5. Atrophy

Related Drugs and Biologics

1. Biomarkers (Surrogate Marker)
2. Retinaldehyde (Retinal)
3. Retinal Pigments (Pigments, Visual)
4. Ranibizumab (Lucentis)
5. Bevacizumab (Avastin)
6. aflibercept
7. chemotactic factor inactivator
8. brolucizumab

Related Therapies and Procedures

1. Intravitreal Injections